Simplifying Vaccine Access Translates to Better Uptake
Drug Topics
JANUARY 3, 2025
Researchers explored ideas of simplifying the vaccination process to yield higher rates of adult immunization, similar to that of the COVID-19 pandemic.
Drug Topics
JANUARY 3, 2025
Researchers explored ideas of simplifying the vaccination process to yield higher rates of adult immunization, similar to that of the COVID-19 pandemic.
STAT
DECEMBER 30, 2024
Although bipartisan legislation to provide Medicare coverage for obesity treatments has circulated in Congress for more than a decade, the Congressional Budget Office (CBO) ventured to estimate the budgetary effects of such a policy for older Americans starting in 2026 for the very first time in a report published in October. The CBO should be commended for conducting this comprehensive analysis.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
JANUARY 2, 2025
A handful of innovative startups are scrambling to gain a foothold as technology improves at a rapid clip.
European Pharmaceutical Review
JANUARY 3, 2025
Researchers have developed a high performance liquid chromatography (HPLC) method that enables accurate determination and precise impurity analysis of the adrenergic -receptor blocker Carvedilol. Carvedilol is commonly used drug to treat cardiovascular diseases , Yuan et al. explained. While there are a variety of methods that can detect and quantify carvedilol, these methods often have limitations in terms of sensitivity, selectivity, or the ability to simultaneously quantify carvedilol and its
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
DECEMBER 31, 2024
Check out this list of our top 5 most read obesity stories from the year 2024.
STAT
DECEMBER 30, 2024
Work by device manufacturers to improve the performance of pulse oximeters on people with darker skin has progressed little since the Food and Drug Administration asked manufacturers in 2013 to voluntarily test the devices on more diverse skin tones, according to a study published Monday in JAMA. The study and a related editorial suggest clearer guidance, enforcement, and possibly legal action may be necessary to ensure the devices work well on all skin tones.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
The Checkup by Singlecare
JANUARY 3, 2025
Contrave is a brand-name medication approved by the U.S. Food and Drug Administration (FDA) for chronic (long-term) weight management in certain adults. It should be taken with a reduced-calorie diet and increased physical activity. As a combination drug that contains an opioid antagonist and antidepressant, it affects the brain to make you feel fuller and lower your appetite.
Drug Topics
DECEMBER 28, 2024
Check out this list of our top 5 most read infectious disease stories from the year 2024.
STAT
DECEMBER 30, 2024
Axsome Therapeutics is moving ahead with plans to submit its Alzheimer’s disease treatment for Food and Drug Administration approval despite mixed results from two new clinical trial readouts. Axsome, which is based in New York, announced Monday that its drug AXS-05 met the primary endpoint of one trial testing the therapy for agitation caused by Alzheimer’s, but failed to show statistical significance in another.
Med Ed 101
JANUARY 1, 2025
I’ve compiled this YouTube video to help candidates best prepare for their 2025 BCPS pharmacy exam. Pass rates continue to be in the 60% range so it is difficult to pass this exam. There are significant changes this year in the 2025 BCPS Exam compared to last spring. The content outline has shifted significantly. Here […] The post 2025 BCPS Pharmacy Exam – What You Need To Know appeared first on Med Ed 101.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Checkup by Singlecare
DECEMBER 30, 2024
Sold under brand names such as Amvaz, Katerzia, Norliqva, and Norvasc , amlodipine is a medication that is FDA approved for the treatment of hypertension (high blood pressure), chronic stable angina (chest pain and pressure), vasospastic angina (coronary artery spasm), and coronary artery disease. It belongs to a class of medications called calcium channel blockers, which is further broken down into two classes: dihydropyridine calcium channel blockers and nondihydropyridine calcium channel bloc
Drug Topics
JANUARY 3, 2025
Researchers aimed to identify the barriers impeding HPV vaccine uptake since 2019 among US mid-adults aged 27 to 45.
Pharma Marketing Network
DECEMBER 31, 2024
Table of Contents Sr# Headings 1 Introduction: The Pharma Marketing Challenge 2 Building a Winning Pharma Marketing Strategy 3 The Role of Branded Drug Campaigns 4 Innovating for Future Success Introduction: The Pharma Marketing Challenge Marketing pharmaceuticals is no small feat. In an industry where lives are at stake, creating compelling, compliant, and effective campaigns can feel like walking a tightrope.
Pharmacy Times
DECEMBER 31, 2024
Bispecific antibodies amivantamab and tarlatamab hold promise for patients.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The Checkup by Singlecare
DECEMBER 30, 2024
Gabapentin is a prescription anticonvulsant drug (aka an anti-seizure medication) and pain medication. It can help treat seizures and relieve anxiety. According to a 2024 study in Animals, gabapentin is also safe and well-tolerated for dogs with behavior disorders. As far as pain management, dogs who have degenerative joint diseases or nerve pain may need gabapentin to treat chronic pain or neuropathic pain.
Drug Topics
JANUARY 3, 2025
A study found that sending a letter to providers about standards of care and glucagon preparations could increase glucagon prescription rates.
Fierce Healthcare
JANUARY 3, 2025
Mimicking prior federal and state investigations into drug manufacturers, health insurer Aetna is suing in Connecticut for rigging the generic drug market.
Pharmacy Times
JANUARY 2, 2025
Over 70% of children and young people with long COVID reported improvements in their symptoms within 24 months of their initial positive SARS-CoV-2 test.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Checkup by Singlecare
DECEMBER 31, 2024
Prednisone is an FDA-approved prescription medication to treat a range of common conditions characterized by inflammation caused by the immune system. It belongs to a class of drugs called corticosteroids (sometimes called glucocorticoids ). Like other steroids, prednisone reduces swelling, redness, and other symptoms caused by immune system reactions.
Drug Topics
JANUARY 2, 2025
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses the benefits of glucagon and why pharmacists should be able to prescribe it.
Fierce Healthcare
JANUARY 2, 2025
In this month's payer roundup, CVS faces antitrust questions from Congress as the company lays off more workers following a failed Medicaid bid in Kansas, Oscar Health CEO Mark Bertolini has a bold idea to remake health insurance and Johnson & Johnson is suing Express Scripts in a long-running lawsuit.
Pharmacy Times
DECEMBER 31, 2024
The potential treatments include ivermectin, methylene blue, glucagon-like peptide-1 receptor agonists, and low-dose naltrexone.
The Checkup by Singlecare
DECEMBER 30, 2024
Soma, the brand name for the generic medication Carisoprodol, is a muscle relaxant given to those with pain related to musculoskeletal conditions. The prescription drug is part of the skeletal muscle relaxant class of medications. Due to the risk of substance abuse on this medicine, some may wonder if Soma is considered a controlled substance. We went to the medical experts to learn everything you want to know about Soma and its potential for drug abuse.
Drug Topics
JANUARY 2, 2025
Jennifer Goldman, PharmD, CDCES, BC-ADM, discusses how putting glucagon kits in public areas and long-term care facilities can help patients with diabetes.
DiversifyRx
JANUARY 2, 2025
KPI optimization is critical to improving the performance of your independent pharmacy. If you dont measure it, you cant improve itthis statement has never been truer for pharmacy owners. Key Performance Indicators (KPIs) are the benchmarks of success, providing insights into your pharmacys performance and guiding smarter decisions. Yet, many pharmacy owners overlook this critical aspect, focusing on day-to-day operations without a clear picture of their businesss health.
Pharmacy Times
DECEMBER 31, 2024
Constantine Tam, MD, discusses zanubrutinib's efficacy in CLL/SLL, emphasizing its durability, high response rates, safety considerations, and evolving therapeutic potential in combination with other agents.
The Checkup by Singlecare
DECEMBER 31, 2024
Prednisone is a medication used to decrease irritation and inflammation in the body. It belongs to a class of drugs called glucocorticoids. There are many different conditions that prednisone is used for, including allergies, asthma, dermatitis, inflammatory bowel disease, arthritis, lymphoma, and leukemia. Its even used for organ transplantation in adults.
Drug Topics
JANUARY 1, 2025
Check out this list of our top 5 most read immunization stories from the year 2024.
Blog: Ask a Student Pharmacist
DECEMBER 31, 2024
Frances Abanonu: the power of childhood dreams eomizowh Tue, 12/31/2024 - 12:11 Author: Erin Wilson Third-year PharmD student Frances Abanonu knew at age 11 that she wanted to be a pharmacist. Her early career ambitions stemmed from her father, who was chronically ill and passed away when she was very young. She told herself then that she would grow up to manufacture drugs that would keep others alive.
Pharmacy Times
DECEMBER 31, 2024
Adding HIV/AIDS to core chronic diseases is a key change.
The Checkup by Singlecare
DECEMBER 30, 2024
Veterinarians do not use the skeletal muscle relaxant tizanidine in dogs. There are no veterinary studies on the effects or safety of tizanidine in companion animals and no published dosages. If a dog is given or accidentally eats tizanidine, thats a potential veterinary emergency requiring inducing vomiting or monitoring the dog in a veterinary clinic.
Drug Topics
DECEMBER 31, 2024
Check out this list of our top 5 most read nonopioid pain management stories from the year 2024.
PharmaVoice
JANUARY 3, 2025
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end of recent annual tallies.
Let's personalize your content